文献

J-GLOBAL ID：201702203562613997   整理番号：17A0976505

化学療法誘発心臓毒性に対するグレリンとデスアシルグレリンの治療可能性

Therapeutic potential of ghrelin and des-acyl ghrelin against chemotherapy-induced cardiotoxicity

著者 (14件)： Nonaka Miki (Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan) ,  Kurebayashi Nagomi (Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan) ,  Murayama Takashi (Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan) ,  Sugihara Masami (Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan) ,  Terawaki Kiyoshi (Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan) ,  Terawaki Kiyoshi (Tsumura Kampo Research Laboratories, Kampo Research & Development Division, Tsumura & Co., Ibaraki 300-1192, Japan) ,  Shiraishi Seiji (Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan) ,  Miyano Kanako (Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan) ,  Hosoda Hiroshi (Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center Research Institute, Suita 565-8565, Japan) ,  Kishida Shosei (Department of Biochemistry and Genetics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan) ,  Kangawa Kenji (National Cerebral and Cardiovascular Center Research Institute, Suita 565-8565, Japan) ,  Sakurai Takashi (Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan) ,  Uezono Yasuhito (Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan) ,  Uezono Yasuhito (Division of Supportive Care Research, National Cancer Center, Exploratory Oncology Research & Clinical Trial Center, Tokyo 104-0045, Japan)
資料名： Endocrine Journal  (Endocrine Journal)
巻： 64  号： Suppl.  ページ： S35-S39(J-STAGE)  発行年： 2017年 
JST資料番号： F0625A  ISSN： 0918-8959  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

シソーラス用語： *グレリン ,...
準シソーラス用語： H9c2細胞 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0976505&from=J-GLOBAL&jstjournalNo=F0625A") }}

著者キーワード (5件)： Cardiotoxicity ,  Chemotherapy ,  Des-acyl ghrelin ,  Doxorubicin ,  Ghrelin

分類 (3件)： 生理活性ペプチド  (EB08100U) ,  中毒一般  (GD06010Q) ,  心臓  (EJ04020D)

物質索引 (1件)： ドキソルビシン

引用文献 (14件)：

• 1. Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, et al. (2015) Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 45: 884-891.
• 2. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, et al. (2011) Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 41: 40-51.
• 3. Khakoo AY, Yeh ET (2008) Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nat Clin Pract Oncol 5: 655-667.
• 4. Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65: 157-170.
• 5. Burridge PW, Li YF (2016) Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med 22: 547-556.

タイトルに関連する用語 (7件)： 化学療法 ,  誘発 ,  心臓毒性 ,  グレリン ,  デスアシルグレリン ,  治療 ,  可能性